His primary scientific interests are in Cancer, Internal medicine, Cancer research, Oncology and Pathology. His Cancer research is multidisciplinary, relying on both Surgical oncology and microRNA. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery.
His Cancer research research includes elements of Epithelial–mesenchymal transition, Downregulation and upregulation, Gene expression profiling, Immunology and Colorectal cancer. Yuichiro Doki focuses mostly in the field of Oncology, narrowing it down to topics relating to Gemcitabine and, in certain cases, Pancreatic cancer. His Pathology research includes themes of Stomach cancer, Cadherin, Oncogene and Gastrointestinal cancer.
Yuichiro Doki mainly focuses on Internal medicine, Surgery, Cancer, Cancer research and Oncology. Internal medicine connects with themes related to Gastroenterology in his study. His work carried out in the field of Surgery brings together such families of science as Gastrectomy and General surgery.
His Cancer research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Pathology. Yuichiro Doki combines subjects such as Cell growth, Cancer cell, Cancer stem cell and Apoptosis, Cell cycle with his study of Cancer research. His biological study spans a wide range of topics, including Survival rate, Carcinoma and Cisplatin.
Yuichiro Doki spends much of his time researching Internal medicine, Cancer, Surgery, Cancer research and Gastroenterology. His Internal medicine study frequently links to adjacent areas such as Oncology. The study incorporates disciplines such as Immunohistochemistry, Incidence and Disease in addition to Cancer.
He is involved in the study of Surgery that focuses on Laparoscopic surgery in particular. In his study, Gene knockdown and Stage is inextricably linked to Colorectal cancer, which falls within the broad field of Cancer research. The various areas that Yuichiro Doki examines in his Gastroenterology study include Multivariate analysis, Adverse effect, Retrospective cohort study, Hazard ratio and Abdominal surgery.
His primary areas of investigation include Cancer, Internal medicine, Cancer research, Esophageal cancer and Gastroenterology. His research integrates issues of Immunohistochemistry and Multivariate analysis in his study of Cancer. His Internal medicine study frequently involves adjacent topics like Oncology.
His studies deal with areas such as Cell culture, Pancreatic cancer, Cancer cell, Cancer stem cell and Colorectal cancer as well as Cancer research. His Colorectal cancer study combines topics in areas such as Surgery and Gene knockdown. His Esophageal cancer study integrates concerns from other disciplines, such as Esophagus, Surgical oncology, Chemotherapy and Cardiothoracic surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reprogramming of mouse and human cells to pluripotency using mature microRNAs.
Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Hiroaki Nagano;Naotsugu Haraguchi.
Cell Stem Cell (2011)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi;Hideshi Ishii;Hideshi Ishii;Koshi Mimori;Fumiaki Tanaka.
Journal of Clinical Investigation (2010)
Expression of Immunoreactive E-Cadherin Adhesion Molecules in Human Cancers
H Shiozaki;H Tahara;H Oka;M Miyata.
American Journal of Pathology (1991)
Thoracic and cardiovascular surgery in Japan during 2014 : Annual report by The Japanese Association for Thoracic Surgery.
Munetaka Masuda;Meinoshin Okumura;Yuichiro Doki.
The Japanese Journal of Thoracic and Cardiovascular Surgery (2016)
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
Satoshi Shimizu;Tetsuo Takehara;Hayato Hikita;Takahiro Kodama.
Journal of Hepatology (2010)
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
T Matsumura;K Sugimachi;H Iinuma;Y Takahashi.
British Journal of Cancer (2015)
Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito;Hiroyoshi Nishikawa;Hiroyoshi Nishikawa;Hisashi Wada;Yuji Nagano.
Nature Medicine (2016)
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.
Yoshito Tomimaru;Hidetoshi Eguchi;Hiroaki Nagano;Hiroshi Wada.
Journal of Hepatology (2012)
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.
Hiroyuki Kuwano;Yasumasa Nishimura;Tsuneo Oyama;Hiroyuki Kato.
Defined factors induce reprogramming of gastrointestinal cancer cells
Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Ken Ichi Nagai;Hiromitsu Hoshino.
Proceedings of the National Academy of Sciences of the United States of America (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: